nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ADRA2A—Brimonidine—glaucoma	0.0849	0.119	CbGbCtD
Doxazosin—ADRA2A—Apraclonidine—glaucoma	0.0849	0.119	CbGbCtD
Doxazosin—ADRA1A—Apraclonidine—glaucoma	0.0814	0.114	CbGbCtD
Doxazosin—ADRA2A—Dipivefrin—glaucoma	0.0678	0.0948	CbGbCtD
Doxazosin—ADRA1A—Dipivefrin—glaucoma	0.065	0.0908	CbGbCtD
Doxazosin—ADRA1D—Clonidine—glaucoma	0.0588	0.0822	CbGbCtD
Doxazosin—ADRA1B—Clonidine—glaucoma	0.0428	0.0598	CbGbCtD
Doxazosin—ADRA2A—Clonidine—glaucoma	0.0352	0.0492	CbGbCtD
Doxazosin—ADRA1A—Clonidine—glaucoma	0.0338	0.0472	CbGbCtD
Doxazosin—CYP2D6—Carteolol—glaucoma	0.0317	0.0442	CbGbCtD
Doxazosin—CYP2D6—Betaxolol—glaucoma	0.0214	0.0299	CbGbCtD
Doxazosin—CYP2C19—Methazolamide—glaucoma	0.0213	0.0298	CbGbCtD
Doxazosin—CYP2C19—Timolol—glaucoma	0.0181	0.0253	CbGbCtD
Doxazosin—CYP2D6—Methazolamide—glaucoma	0.0162	0.0226	CbGbCtD
Doxazosin—ABCB1—Timolol—glaucoma	0.0146	0.0204	CbGbCtD
Doxazosin—CYP2D6—Timolol—glaucoma	0.0138	0.0193	CbGbCtD
Doxazosin—ABCB1—Clonidine—glaucoma	0.0124	0.0174	CbGbCtD
Doxazosin—CYP2D6—Clonidine—glaucoma	0.0117	0.0164	CbGbCtD
Doxazosin—Asthenia—Bimatoprost—glaucoma	0.000133	0.000495	CcSEcCtD
Doxazosin—Fatigue—Brinzolamide—glaucoma	0.000133	0.000494	CcSEcCtD
Doxazosin—Dyspnoea—Pilocarpine—glaucoma	0.000132	0.000491	CcSEcCtD
Doxazosin—Pain—Brinzolamide—glaucoma	0.000132	0.00049	CcSEcCtD
Doxazosin—Somnolence—Pilocarpine—glaucoma	0.000132	0.00049	CcSEcCtD
Doxazosin—Depression—Timolol—glaucoma	0.000131	0.000489	CcSEcCtD
Doxazosin—Pruritus—Bimatoprost—glaucoma	0.000131	0.000488	CcSEcCtD
Doxazosin—Diarrhoea—Apraclonidine—glaucoma	0.000131	0.000487	CcSEcCtD
Doxazosin—Malaise—Clonidine—glaucoma	0.000131	0.000486	CcSEcCtD
Doxazosin—Dyspepsia—Pilocarpine—glaucoma	0.00013	0.000485	CcSEcCtD
Doxazosin—Chills—Betaxolol—glaucoma	0.00013	0.000484	CcSEcCtD
Doxazosin—Syncope—Clonidine—glaucoma	0.00013	0.000484	CcSEcCtD
Doxazosin—Arrhythmia—Betaxolol—glaucoma	0.000129	0.000482	CcSEcCtD
Doxazosin—Feeling abnormal—Dorzolamide—glaucoma	0.000129	0.000481	CcSEcCtD
Doxazosin—Decreased appetite—Pilocarpine—glaucoma	0.000129	0.000479	CcSEcCtD
Doxazosin—Feeling abnormal—Travoprost—glaucoma	0.000128	0.000479	CcSEcCtD
Doxazosin—Conjunctivitis—Timolol—glaucoma	0.000128	0.000477	CcSEcCtD
Doxazosin—Gastrointestinal pain—Dorzolamide—glaucoma	0.000128	0.000477	CcSEcCtD
Doxazosin—Alopecia—Betaxolol—glaucoma	0.000128	0.000477	CcSEcCtD
Doxazosin—Palpitations—Clonidine—glaucoma	0.000128	0.000477	CcSEcCtD
Doxazosin—Gastrointestinal pain—Travoprost—glaucoma	0.000127	0.000475	CcSEcCtD
Doxazosin—Loss of consciousness—Clonidine—glaucoma	0.000127	0.000474	CcSEcCtD
Doxazosin—Feeling abnormal—Brinzolamide—glaucoma	0.000127	0.000473	CcSEcCtD
Doxazosin—Mental disorder—Betaxolol—glaucoma	0.000127	0.000473	CcSEcCtD
Doxazosin—Pain—Pilocarpine—glaucoma	0.000127	0.000471	CcSEcCtD
Doxazosin—Constipation—Pilocarpine—glaucoma	0.000127	0.000471	CcSEcCtD
Doxazosin—Cough—Clonidine—glaucoma	0.000126	0.000471	CcSEcCtD
Doxazosin—Sweating—Timolol—glaucoma	0.000126	0.000471	CcSEcCtD
Doxazosin—Dizziness—Apraclonidine—glaucoma	0.000126	0.000471	CcSEcCtD
Doxazosin—Malnutrition—Betaxolol—glaucoma	0.000126	0.00047	CcSEcCtD
Doxazosin—Urticaria—Dorzolamide—glaucoma	0.000124	0.000463	CcSEcCtD
Doxazosin—Epistaxis—Timolol—glaucoma	0.000124	0.000463	CcSEcCtD
Doxazosin—Abdominal pain—Dorzolamide—glaucoma	0.000124	0.000461	CcSEcCtD
Doxazosin—Body temperature increased—Dorzolamide—glaucoma	0.000124	0.000461	CcSEcCtD
Doxazosin—Tension—Betaxolol—glaucoma	0.000124	0.000461	CcSEcCtD
Doxazosin—Sinusitis—Timolol—glaucoma	0.000124	0.000461	CcSEcCtD
Doxazosin—Dysgeusia—Betaxolol—glaucoma	0.000123	0.00046	CcSEcCtD
Doxazosin—Chest pain—Clonidine—glaucoma	0.000123	0.000459	CcSEcCtD
Doxazosin—Arthralgia—Clonidine—glaucoma	0.000123	0.000459	CcSEcCtD
Doxazosin—Abdominal pain—Travoprost—glaucoma	0.000123	0.000459	CcSEcCtD
Doxazosin—Anxiety—Clonidine—glaucoma	0.000123	0.000458	CcSEcCtD
Doxazosin—Asthenia—Acetazolamide—glaucoma	0.000123	0.000457	CcSEcCtD
Doxazosin—Dizziness—Bimatoprost—glaucoma	0.000122	0.000456	CcSEcCtD
Doxazosin—Nervousness—Betaxolol—glaucoma	0.000122	0.000456	CcSEcCtD
Doxazosin—Urticaria—Brinzolamide—glaucoma	0.000122	0.000456	CcSEcCtD
Doxazosin—Feeling abnormal—Pilocarpine—glaucoma	0.000122	0.000454	CcSEcCtD
Doxazosin—Discomfort—Clonidine—glaucoma	0.000122	0.000454	CcSEcCtD
Doxazosin—Vomiting—Apraclonidine—glaucoma	0.000121	0.000452	CcSEcCtD
Doxazosin—Muscle spasms—Betaxolol—glaucoma	0.000121	0.000451	CcSEcCtD
Doxazosin—Gastrointestinal pain—Pilocarpine—glaucoma	0.000121	0.000451	CcSEcCtD
Doxazosin—Hypersensitivity—Brimonidine—glaucoma	0.000121	0.00045	CcSEcCtD
Doxazosin—Dry mouth—Clonidine—glaucoma	0.000121	0.000449	CcSEcCtD
Doxazosin—Bradycardia—Timolol—glaucoma	0.00012	0.000449	CcSEcCtD
Doxazosin—Dermatitis—Apraclonidine—glaucoma	0.00012	0.000448	CcSEcCtD
Doxazosin—Headache—Apraclonidine—glaucoma	0.00012	0.000446	CcSEcCtD
Doxazosin—Confusional state—Clonidine—glaucoma	0.000119	0.000444	CcSEcCtD
Doxazosin—Vision blurred—Betaxolol—glaucoma	0.000119	0.000443	CcSEcCtD
Doxazosin—Rhinitis—Timolol—glaucoma	0.000119	0.000442	CcSEcCtD
Doxazosin—Oedema—Clonidine—glaucoma	0.000118	0.00044	CcSEcCtD
Doxazosin—Tremor—Betaxolol—glaucoma	0.000118	0.00044	CcSEcCtD
Doxazosin—Asthenia—Brimonidine—glaucoma	0.000118	0.000438	CcSEcCtD
Doxazosin—Infection—Clonidine—glaucoma	0.000117	0.000437	CcSEcCtD
Doxazosin—Body temperature increased—Pilocarpine—glaucoma	0.000117	0.000436	CcSEcCtD
Doxazosin—Abdominal pain—Pilocarpine—glaucoma	0.000117	0.000436	CcSEcCtD
Doxazosin—Ill-defined disorder—Betaxolol—glaucoma	0.000117	0.000436	CcSEcCtD
Doxazosin—Diarrhoea—Acetazolamide—glaucoma	0.000117	0.000435	CcSEcCtD
Doxazosin—Rash—Bimatoprost—glaucoma	0.000117	0.000435	CcSEcCtD
Doxazosin—Dermatitis—Bimatoprost—glaucoma	0.000117	0.000435	CcSEcCtD
Doxazosin—Shock—Clonidine—glaucoma	0.000116	0.000433	CcSEcCtD
Doxazosin—Pruritus—Brimonidine—glaucoma	0.000116	0.000432	CcSEcCtD
Doxazosin—Headache—Bimatoprost—glaucoma	0.000116	0.000432	CcSEcCtD
Doxazosin—Thrombocytopenia—Clonidine—glaucoma	0.000116	0.000431	CcSEcCtD
Doxazosin—Hypersensitivity—Dorzolamide—glaucoma	0.000115	0.00043	CcSEcCtD
Doxazosin—Tachycardia—Clonidine—glaucoma	0.000115	0.00043	CcSEcCtD
Doxazosin—Hypersensitivity—Travoprost—glaucoma	0.000115	0.000428	CcSEcCtD
Doxazosin—Skin disorder—Clonidine—glaucoma	0.000115	0.000428	CcSEcCtD
Doxazosin—Hyperhidrosis—Clonidine—glaucoma	0.000114	0.000426	CcSEcCtD
Doxazosin—Visual impairment—Timolol—glaucoma	0.000114	0.000425	CcSEcCtD
Doxazosin—Malaise—Betaxolol—glaucoma	0.000114	0.000423	CcSEcCtD
Doxazosin—Nausea—Apraclonidine—glaucoma	0.000113	0.000423	CcSEcCtD
Doxazosin—Hypersensitivity—Brinzolamide—glaucoma	0.000113	0.000423	CcSEcCtD
Doxazosin—Vertigo—Betaxolol—glaucoma	0.000113	0.000422	CcSEcCtD
Doxazosin—Syncope—Betaxolol—glaucoma	0.000113	0.000421	CcSEcCtD
Doxazosin—Dizziness—Acetazolamide—glaucoma	0.000113	0.000421	CcSEcCtD
Doxazosin—Anorexia—Clonidine—glaucoma	0.000113	0.00042	CcSEcCtD
Doxazosin—Asthenia—Dorzolamide—glaucoma	0.000112	0.000419	CcSEcCtD
Doxazosin—Asthenia—Travoprost—glaucoma	0.000112	0.000417	CcSEcCtD
Doxazosin—Palpitations—Betaxolol—glaucoma	0.000111	0.000415	CcSEcCtD
Doxazosin—Pruritus—Dorzolamide—glaucoma	0.000111	0.000413	CcSEcCtD
Doxazosin—Loss of consciousness—Betaxolol—glaucoma	0.000111	0.000413	CcSEcCtD
Doxazosin—Eye disorder—Timolol—glaucoma	0.000111	0.000412	CcSEcCtD
Doxazosin—Asthenia—Brinzolamide—glaucoma	0.00011	0.000411	CcSEcCtD
Doxazosin—Hypotension—Clonidine—glaucoma	0.00011	0.000411	CcSEcCtD
Doxazosin—Pruritus—Travoprost—glaucoma	0.00011	0.000411	CcSEcCtD
Doxazosin—Tinnitus—Timolol—glaucoma	0.00011	0.000411	CcSEcCtD
Doxazosin—Cough—Betaxolol—glaucoma	0.00011	0.00041	CcSEcCtD
Doxazosin—Nausea—Bimatoprost—glaucoma	0.00011	0.00041	CcSEcCtD
Doxazosin—Hypersensitivity—Pilocarpine—glaucoma	0.000109	0.000406	CcSEcCtD
Doxazosin—Pruritus—Brinzolamide—glaucoma	0.000109	0.000406	CcSEcCtD
Doxazosin—Vomiting—Acetazolamide—glaucoma	0.000109	0.000405	CcSEcCtD
Doxazosin—Dizziness—Brimonidine—glaucoma	0.000108	0.000404	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Clonidine—glaucoma	0.000108	0.000401	CcSEcCtD
Doxazosin—Myalgia—Betaxolol—glaucoma	0.000107	0.0004	CcSEcCtD
Doxazosin—Chest pain—Betaxolol—glaucoma	0.000107	0.0004	CcSEcCtD
Doxazosin—Arthralgia—Betaxolol—glaucoma	0.000107	0.0004	CcSEcCtD
Doxazosin—Diarrhoea—Dorzolamide—glaucoma	0.000107	0.000399	CcSEcCtD
Doxazosin—Headache—Acetazolamide—glaucoma	0.000107	0.000399	CcSEcCtD
Doxazosin—Anxiety—Betaxolol—glaucoma	0.000107	0.000398	CcSEcCtD
Doxazosin—Insomnia—Clonidine—glaucoma	0.000107	0.000398	CcSEcCtD
Doxazosin—Diarrhoea—Travoprost—glaucoma	0.000107	0.000397	CcSEcCtD
Doxazosin—Asthenia—Pilocarpine—glaucoma	0.000106	0.000395	CcSEcCtD
Doxazosin—Paraesthesia—Clonidine—glaucoma	0.000106	0.000395	CcSEcCtD
Doxazosin—Discomfort—Betaxolol—glaucoma	0.000106	0.000395	CcSEcCtD
Doxazosin—Arrhythmia—Timolol—glaucoma	0.000106	0.000394	CcSEcCtD
Doxazosin—Dyspnoea—Clonidine—glaucoma	0.000105	0.000392	CcSEcCtD
Doxazosin—Diarrhoea—Brinzolamide—glaucoma	0.000105	0.000392	CcSEcCtD
Doxazosin—Somnolence—Clonidine—glaucoma	0.000105	0.000391	CcSEcCtD
Doxazosin—Dry mouth—Betaxolol—glaucoma	0.000105	0.000391	CcSEcCtD
Doxazosin—Pruritus—Pilocarpine—glaucoma	0.000105	0.00039	CcSEcCtD
Doxazosin—Alopecia—Timolol—glaucoma	0.000105	0.000389	CcSEcCtD
Doxazosin—Confusional state—Betaxolol—glaucoma	0.000104	0.000386	CcSEcCtD
Doxazosin—Mental disorder—Timolol—glaucoma	0.000104	0.000386	CcSEcCtD
Doxazosin—Dizziness—Dorzolamide—glaucoma	0.000104	0.000386	CcSEcCtD
Doxazosin—Rash—Brimonidine—glaucoma	0.000103	0.000385	CcSEcCtD
Doxazosin—Dermatitis—Brimonidine—glaucoma	0.000103	0.000385	CcSEcCtD
Doxazosin—Dizziness—Travoprost—glaucoma	0.000103	0.000384	CcSEcCtD
Doxazosin—Malnutrition—Timolol—glaucoma	0.000103	0.000384	CcSEcCtD
Doxazosin—Oedema—Betaxolol—glaucoma	0.000103	0.000383	CcSEcCtD
Doxazosin—Headache—Brimonidine—glaucoma	0.000103	0.000383	CcSEcCtD
Doxazosin—Decreased appetite—Clonidine—glaucoma	0.000103	0.000383	CcSEcCtD
Doxazosin—Infection—Betaxolol—glaucoma	0.000102	0.000381	CcSEcCtD
Doxazosin—Fatigue—Clonidine—glaucoma	0.000102	0.00038	CcSEcCtD
Doxazosin—Dizziness—Brinzolamide—glaucoma	0.000102	0.000379	CcSEcCtD
Doxazosin—Nausea—Acetazolamide—glaucoma	0.000101	0.000378	CcSEcCtD
Doxazosin—Diarrhoea—Pilocarpine—glaucoma	0.000101	0.000377	CcSEcCtD
Doxazosin—Shock—Betaxolol—glaucoma	0.000101	0.000377	CcSEcCtD
Doxazosin—Tension—Timolol—glaucoma	0.000101	0.000376	CcSEcCtD
Doxazosin—Constipation—Clonidine—glaucoma	0.000101	0.000376	CcSEcCtD
Doxazosin—Pain—Clonidine—glaucoma	0.000101	0.000376	CcSEcCtD
Doxazosin—Dysgeusia—Timolol—glaucoma	0.000101	0.000376	CcSEcCtD
Doxazosin—Thrombocytopenia—Betaxolol—glaucoma	0.000101	0.000375	CcSEcCtD
Doxazosin—Tachycardia—Betaxolol—glaucoma	0.0001	0.000374	CcSEcCtD
Doxazosin—Nervousness—Timolol—glaucoma	0.0001	0.000373	CcSEcCtD
Doxazosin—Skin disorder—Betaxolol—glaucoma	9.99e-05	0.000372	CcSEcCtD
Doxazosin—Vomiting—Dorzolamide—glaucoma	9.95e-05	0.000371	CcSEcCtD
Doxazosin—Hyperhidrosis—Betaxolol—glaucoma	9.94e-05	0.00037	CcSEcCtD
Doxazosin—Rash—Dorzolamide—glaucoma	9.87e-05	0.000368	CcSEcCtD
Doxazosin—Dermatitis—Dorzolamide—glaucoma	9.86e-05	0.000367	CcSEcCtD
Doxazosin—Rash—Travoprost—glaucoma	9.83e-05	0.000366	CcSEcCtD
Doxazosin—Dermatitis—Travoprost—glaucoma	9.82e-05	0.000366	CcSEcCtD
Doxazosin—Headache—Dorzolamide—glaucoma	9.81e-05	0.000365	CcSEcCtD
Doxazosin—Anorexia—Betaxolol—glaucoma	9.8e-05	0.000365	CcSEcCtD
Doxazosin—Vomiting—Brinzolamide—glaucoma	9.79e-05	0.000365	CcSEcCtD
Doxazosin—Dizziness—Pilocarpine—glaucoma	9.78e-05	0.000365	CcSEcCtD
Doxazosin—Headache—Travoprost—glaucoma	9.77e-05	0.000364	CcSEcCtD
Doxazosin—Nausea—Brimonidine—glaucoma	9.74e-05	0.000363	CcSEcCtD
Doxazosin—Feeling abnormal—Clonidine—glaucoma	9.74e-05	0.000363	CcSEcCtD
Doxazosin—Rash—Brinzolamide—glaucoma	9.7e-05	0.000362	CcSEcCtD
Doxazosin—Vision blurred—Timolol—glaucoma	9.7e-05	0.000362	CcSEcCtD
Doxazosin—Dermatitis—Brinzolamide—glaucoma	9.7e-05	0.000361	CcSEcCtD
Doxazosin—Gastrointestinal pain—Clonidine—glaucoma	9.66e-05	0.00036	CcSEcCtD
Doxazosin—Headache—Brinzolamide—glaucoma	9.64e-05	0.000359	CcSEcCtD
Doxazosin—Hypotension—Betaxolol—glaucoma	9.61e-05	0.000358	CcSEcCtD
Doxazosin—Vomiting—Pilocarpine—glaucoma	9.41e-05	0.00035	CcSEcCtD
Doxazosin—Urticaria—Clonidine—glaucoma	9.39e-05	0.00035	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Betaxolol—glaucoma	9.37e-05	0.000349	CcSEcCtD
Doxazosin—Abdominal pain—Clonidine—glaucoma	9.34e-05	0.000348	CcSEcCtD
Doxazosin—Body temperature increased—Clonidine—glaucoma	9.34e-05	0.000348	CcSEcCtD
Doxazosin—Rash—Pilocarpine—glaucoma	9.33e-05	0.000348	CcSEcCtD
Doxazosin—Dermatitis—Pilocarpine—glaucoma	9.32e-05	0.000347	CcSEcCtD
Doxazosin—Insomnia—Betaxolol—glaucoma	9.3e-05	0.000347	CcSEcCtD
Doxazosin—Nausea—Dorzolamide—glaucoma	9.3e-05	0.000347	CcSEcCtD
Doxazosin—Headache—Pilocarpine—glaucoma	9.27e-05	0.000345	CcSEcCtD
Doxazosin—Nausea—Travoprost—glaucoma	9.26e-05	0.000345	CcSEcCtD
Doxazosin—Vertigo—Timolol—glaucoma	9.25e-05	0.000345	CcSEcCtD
Doxazosin—Paraesthesia—Betaxolol—glaucoma	9.24e-05	0.000344	CcSEcCtD
Doxazosin—Syncope—Timolol—glaucoma	9.23e-05	0.000344	CcSEcCtD
Doxazosin—Dyspnoea—Betaxolol—glaucoma	9.17e-05	0.000342	CcSEcCtD
Doxazosin—Nausea—Brinzolamide—glaucoma	9.14e-05	0.000341	CcSEcCtD
Doxazosin—Palpitations—Timolol—glaucoma	9.1e-05	0.000339	CcSEcCtD
Doxazosin—Dyspepsia—Betaxolol—glaucoma	9.05e-05	0.000337	CcSEcCtD
Doxazosin—Loss of consciousness—Timolol—glaucoma	9.05e-05	0.000337	CcSEcCtD
Doxazosin—Cough—Timolol—glaucoma	8.98e-05	0.000335	CcSEcCtD
Doxazosin—Decreased appetite—Betaxolol—glaucoma	8.94e-05	0.000333	CcSEcCtD
Doxazosin—Hypertension—Timolol—glaucoma	8.89e-05	0.000331	CcSEcCtD
Doxazosin—Fatigue—Betaxolol—glaucoma	8.87e-05	0.00033	CcSEcCtD
Doxazosin—Pain—Betaxolol—glaucoma	8.8e-05	0.000328	CcSEcCtD
Doxazosin—Constipation—Betaxolol—glaucoma	8.8e-05	0.000328	CcSEcCtD
Doxazosin—Nausea—Pilocarpine—glaucoma	8.79e-05	0.000327	CcSEcCtD
Doxazosin—Myalgia—Timolol—glaucoma	8.76e-05	0.000327	CcSEcCtD
Doxazosin—Chest pain—Timolol—glaucoma	8.76e-05	0.000327	CcSEcCtD
Doxazosin—Arthralgia—Timolol—glaucoma	8.76e-05	0.000327	CcSEcCtD
Doxazosin—Anxiety—Timolol—glaucoma	8.73e-05	0.000325	CcSEcCtD
Doxazosin—Hypersensitivity—Clonidine—glaucoma	8.7e-05	0.000324	CcSEcCtD
Doxazosin—Discomfort—Timolol—glaucoma	8.66e-05	0.000323	CcSEcCtD
Doxazosin—Dry mouth—Timolol—glaucoma	8.57e-05	0.000319	CcSEcCtD
Doxazosin—Asthenia—Clonidine—glaucoma	8.48e-05	0.000316	CcSEcCtD
Doxazosin—Feeling abnormal—Betaxolol—glaucoma	8.48e-05	0.000316	CcSEcCtD
Doxazosin—Confusional state—Timolol—glaucoma	8.47e-05	0.000316	CcSEcCtD
Doxazosin—Oedema—Timolol—glaucoma	8.4e-05	0.000313	CcSEcCtD
Doxazosin—Pruritus—Clonidine—glaucoma	8.36e-05	0.000311	CcSEcCtD
Doxazosin—Infection—Timolol—glaucoma	8.35e-05	0.000311	CcSEcCtD
Doxazosin—Shock—Timolol—glaucoma	8.27e-05	0.000308	CcSEcCtD
Doxazosin—Urticaria—Betaxolol—glaucoma	8.17e-05	0.000304	CcSEcCtD
Doxazosin—Skin disorder—Timolol—glaucoma	8.16e-05	0.000304	CcSEcCtD
Doxazosin—Body temperature increased—Betaxolol—glaucoma	8.13e-05	0.000303	CcSEcCtD
Doxazosin—Hyperhidrosis—Timolol—glaucoma	8.12e-05	0.000303	CcSEcCtD
Doxazosin—Diarrhoea—Clonidine—glaucoma	8.08e-05	0.000301	CcSEcCtD
Doxazosin—Anorexia—Timolol—glaucoma	8.01e-05	0.000298	CcSEcCtD
Doxazosin—Hypotension—Timolol—glaucoma	7.85e-05	0.000293	CcSEcCtD
Doxazosin—Dizziness—Clonidine—glaucoma	7.81e-05	0.000291	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Timolol—glaucoma	7.66e-05	0.000285	CcSEcCtD
Doxazosin—Insomnia—Timolol—glaucoma	7.6e-05	0.000283	CcSEcCtD
Doxazosin—Hypersensitivity—Betaxolol—glaucoma	7.58e-05	0.000282	CcSEcCtD
Doxazosin—Paraesthesia—Timolol—glaucoma	7.54e-05	0.000281	CcSEcCtD
Doxazosin—Vomiting—Clonidine—glaucoma	7.51e-05	0.00028	CcSEcCtD
Doxazosin—Dyspnoea—Timolol—glaucoma	7.49e-05	0.000279	CcSEcCtD
Doxazosin—Somnolence—Timolol—glaucoma	7.47e-05	0.000278	CcSEcCtD
Doxazosin—Rash—Clonidine—glaucoma	7.45e-05	0.000278	CcSEcCtD
Doxazosin—Dermatitis—Clonidine—glaucoma	7.44e-05	0.000277	CcSEcCtD
Doxazosin—Headache—Clonidine—glaucoma	7.4e-05	0.000276	CcSEcCtD
Doxazosin—Dyspepsia—Timolol—glaucoma	7.4e-05	0.000276	CcSEcCtD
Doxazosin—Asthenia—Betaxolol—glaucoma	7.38e-05	0.000275	CcSEcCtD
Doxazosin—Decreased appetite—Timolol—glaucoma	7.3e-05	0.000272	CcSEcCtD
Doxazosin—Pruritus—Betaxolol—glaucoma	7.28e-05	0.000271	CcSEcCtD
Doxazosin—Fatigue—Timolol—glaucoma	7.24e-05	0.00027	CcSEcCtD
Doxazosin—Pain—Timolol—glaucoma	7.19e-05	0.000268	CcSEcCtD
Doxazosin—Diarrhoea—Betaxolol—glaucoma	7.04e-05	0.000262	CcSEcCtD
Doxazosin—Nausea—Clonidine—glaucoma	7.02e-05	0.000261	CcSEcCtD
Doxazosin—Feeling abnormal—Timolol—glaucoma	6.92e-05	0.000258	CcSEcCtD
Doxazosin—Gastrointestinal pain—Timolol—glaucoma	6.87e-05	0.000256	CcSEcCtD
Doxazosin—Dizziness—Betaxolol—glaucoma	6.8e-05	0.000253	CcSEcCtD
Doxazosin—Urticaria—Timolol—glaucoma	6.67e-05	0.000249	CcSEcCtD
Doxazosin—Abdominal pain—Timolol—glaucoma	6.64e-05	0.000248	CcSEcCtD
Doxazosin—Body temperature increased—Timolol—glaucoma	6.64e-05	0.000248	CcSEcCtD
Doxazosin—Vomiting—Betaxolol—glaucoma	6.54e-05	0.000244	CcSEcCtD
Doxazosin—Rash—Betaxolol—glaucoma	6.48e-05	0.000242	CcSEcCtD
Doxazosin—Dermatitis—Betaxolol—glaucoma	6.48e-05	0.000241	CcSEcCtD
Doxazosin—Headache—Betaxolol—glaucoma	6.44e-05	0.00024	CcSEcCtD
Doxazosin—Hypersensitivity—Timolol—glaucoma	6.19e-05	0.000231	CcSEcCtD
Doxazosin—Nausea—Betaxolol—glaucoma	6.11e-05	0.000228	CcSEcCtD
Doxazosin—Asthenia—Timolol—glaucoma	6.03e-05	0.000225	CcSEcCtD
Doxazosin—Pruritus—Timolol—glaucoma	5.94e-05	0.000222	CcSEcCtD
Doxazosin—Diarrhoea—Timolol—glaucoma	5.75e-05	0.000214	CcSEcCtD
Doxazosin—Dizziness—Timolol—glaucoma	5.56e-05	0.000207	CcSEcCtD
Doxazosin—Vomiting—Timolol—glaucoma	5.34e-05	0.000199	CcSEcCtD
Doxazosin—Rash—Timolol—glaucoma	5.3e-05	0.000197	CcSEcCtD
Doxazosin—Dermatitis—Timolol—glaucoma	5.29e-05	0.000197	CcSEcCtD
Doxazosin—Headache—Timolol—glaucoma	5.26e-05	0.000196	CcSEcCtD
Doxazosin—Nausea—Timolol—glaucoma	4.99e-05	0.000186	CcSEcCtD
Doxazosin—ADRA1B—GPCR downstream signaling—PTGFR—glaucoma	3.14e-05	0.002	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	3.12e-05	0.00198	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—VEGFA—glaucoma	3.11e-05	0.00198	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—OPN4—glaucoma	3.1e-05	0.00197	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	2.98e-05	0.0019	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.92e-05	0.00186	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—SOD1—glaucoma	2.92e-05	0.00186	CbGpPWpGaD
Doxazosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.91e-05	0.00185	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—OPN4—glaucoma	2.88e-05	0.00183	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PTGFR—glaucoma	2.85e-05	0.00182	CbGpPWpGaD
Doxazosin—CYP2C19—Biological oxidations—CYP1B1—glaucoma	2.83e-05	0.0018	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—OPN4—glaucoma	2.81e-05	0.00179	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—SMO—glaucoma	2.8e-05	0.00178	CbGpPWpGaD
Doxazosin—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	2.79e-05	0.00178	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PTGFR—glaucoma	2.79e-05	0.00178	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—LRP12—glaucoma	2.7e-05	0.00172	CbGpPWpGaD
Doxazosin—ADRA1B—AMPK Signaling—TP53—glaucoma	2.7e-05	0.00172	CbGpPWpGaD
Doxazosin—KCNH2—SIDS Susceptibility Pathways—TNF—glaucoma	2.67e-05	0.0017	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	2.65e-05	0.00168	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—OPN4—glaucoma	2.61e-05	0.00166	CbGpPWpGaD
Doxazosin—CYP2D6—Biological oxidations—CYP1B1—glaucoma	2.6e-05	0.00166	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PTGFR—glaucoma	2.59e-05	0.00165	CbGpPWpGaD
Doxazosin—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	2.57e-05	0.00164	CbGpPWpGaD
Doxazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.55e-05	0.00163	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PTGFR—glaucoma	2.53e-05	0.00161	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CA5A—glaucoma	2.49e-05	0.00159	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NARFL—glaucoma	2.49e-05	0.00159	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—SMO—glaucoma	2.49e-05	0.00158	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CA5A—glaucoma	2.43e-05	0.00155	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NARFL—glaucoma	2.43e-05	0.00155	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.43e-05	0.00154	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—LRP12—glaucoma	2.4e-05	0.00153	CbGpPWpGaD
Doxazosin—ADRA1A—AMPK Signaling—TP53—glaucoma	2.4e-05	0.00153	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PTGFR—glaucoma	2.35e-05	0.0015	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	2.32e-05	0.00148	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—SMO—glaucoma	2.31e-05	0.00147	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CA5A—glaucoma	2.29e-05	0.00146	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NARFL—glaucoma	2.29e-05	0.00146	CbGpPWpGaD
Doxazosin—CYP2C19—Biological oxidations—GSTM1—glaucoma	2.26e-05	0.00144	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—OPN4—glaucoma	2.25e-05	0.00144	CbGpPWpGaD
Doxazosin—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	2.23e-05	0.00142	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—LRP12—glaucoma	2.23e-05	0.00142	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—EDN1—glaucoma	2.23e-05	0.00142	CbGpPWpGaD
Doxazosin—ADRA2A—G alpha (i) signalling events—C3—glaucoma	2.2e-05	0.0014	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.16e-05	0.00137	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	2.14e-05	0.00136	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	2.13e-05	0.00135	CbGpPWpGaD
Doxazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	2.12e-05	0.00135	CbGpPWpGaD
Doxazosin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	2.11e-05	0.00134	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HEYL—glaucoma	2.1e-05	0.00133	CbGpPWpGaD
Doxazosin—CYP2D6—Biological oxidations—GSTM1—glaucoma	2.08e-05	0.00133	CbGpPWpGaD
Doxazosin—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	2.05e-05	0.00131	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTGFR—glaucoma	2.03e-05	0.00129	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—FN1—glaucoma	2.03e-05	0.00129	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2e-05	0.00127	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.99e-05	0.00127	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TGFB2—glaucoma	1.98e-05	0.00126	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR ligand binding—C3—glaucoma	1.94e-05	0.00124	CbGpPWpGaD
Doxazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.88e-05	0.0012	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—OPN4—glaucoma	1.87e-05	0.00119	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—EDN1—glaucoma	1.85e-05	0.00118	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—VEGFA—glaucoma	1.83e-05	0.00116	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.82e-05	0.00116	CbGpPWpGaD
Doxazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.75e-05	0.00111	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HEYL—glaucoma	1.74e-05	0.00111	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—SMO—glaucoma	1.73e-05	0.0011	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CA1—glaucoma	1.72e-05	0.00109	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTGFR—glaucoma	1.69e-05	0.00107	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CTSA—glaucoma	1.66e-05	0.00106	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—OPN4—glaucoma	1.66e-05	0.00106	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—EDN1—glaucoma	1.64e-05	0.00104	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR ligand binding—C3—glaucoma	1.61e-05	0.00103	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RPTOR—glaucoma	1.59e-05	0.00101	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CA2—glaucoma	1.57e-05	0.001	CbGpPWpGaD
Doxazosin—ABCB1—Allograft Rejection—TNF—glaucoma	1.57e-05	0.000998	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.56e-05	0.000992	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HEYL—glaucoma	1.55e-05	0.000984	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—OPN4—glaucoma	1.54e-05	0.000983	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NCK2—glaucoma	1.54e-05	0.000979	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—EDN1—glaucoma	1.53e-05	0.000971	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—SOD1—glaucoma	1.5e-05	0.000957	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTGFR—glaucoma	1.5e-05	0.000953	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.46e-05	0.000927	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—SMO—glaucoma	1.44e-05	0.000915	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HEYL—glaucoma	1.44e-05	0.000914	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR ligand binding—C3—glaucoma	1.43e-05	0.000913	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTGFR—glaucoma	1.39e-05	0.000885	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR ligand binding—C3—glaucoma	1.33e-05	0.000848	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RPTOR—glaucoma	1.32e-05	0.000839	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HDAC9—glaucoma	1.31e-05	0.000833	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—SMO—glaucoma	1.28e-05	0.000813	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NCK2—glaucoma	1.28e-05	0.000813	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—EDN1—glaucoma	1.26e-05	0.000801	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CA1—glaucoma	1.22e-05	0.000774	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CA1—glaucoma	1.19e-05	0.000756	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—SMO—glaucoma	1.19e-05	0.000756	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CTSA—glaucoma	1.18e-05	0.00075	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RPTOR—glaucoma	1.17e-05	0.000745	CbGpPWpGaD
Doxazosin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.16e-05	0.000739	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CTSA—glaucoma	1.15e-05	0.000732	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—MMP1—glaucoma	1.15e-05	0.00073	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.15e-05	0.000729	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—EDN1—glaucoma	1.14e-05	0.000727	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NCK2—glaucoma	1.13e-05	0.000722	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CA1—glaucoma	1.12e-05	0.000712	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CA2—glaucoma	1.11e-05	0.000708	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—TXN—glaucoma	1.11e-05	0.000704	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—C3—glaucoma	1.1e-05	0.0007	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—CAV1—glaucoma	1.1e-05	0.000699	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RPTOR—glaucoma	1.09e-05	0.000693	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.09e-05	0.000692	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.09e-05	0.000692	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CA2—glaucoma	1.09e-05	0.000691	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HDAC9—glaucoma	1.09e-05	0.000691	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.09e-05	0.000691	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CTSA—glaucoma	1.08e-05	0.00069	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NCK2—glaucoma	1.05e-05	0.000671	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—FN1—glaucoma	1.05e-05	0.000666	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—EDN1—glaucoma	1.04e-05	0.000665	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—SMO—glaucoma	1.02e-05	0.000652	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CA2—glaucoma	1.02e-05	0.000651	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—C3—glaucoma	9.98e-06	0.000635	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HDAC9—glaucoma	9.64e-06	0.000614	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EDN1—glaucoma	9.48e-06	0.000604	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NTRK2—glaucoma	9.36e-06	0.000596	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	9.28e-06	0.00059	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—C3—glaucoma	9.12e-06	0.000581	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	9.02e-06	0.000574	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HDAC9—glaucoma	8.96e-06	0.00057	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	8.62e-06	0.000549	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTT1—glaucoma	8.58e-06	0.000546	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SMO—glaucoma	8.5e-06	0.000541	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EDN1—glaucoma	8.42e-06	0.000536	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—NOS3—glaucoma	8.31e-06	0.000529	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—C3—glaucoma	8.28e-06	0.000527	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—C3—glaucoma	8.1e-06	0.000516	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NGFR—glaucoma	8.03e-06	0.000511	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—TXN—glaucoma	7.84e-06	0.000499	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EDN1—glaucoma	7.83e-06	0.000498	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NTRK2—glaucoma	7.77e-06	0.000495	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	7.73e-06	0.000492	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—TXN—glaucoma	7.65e-06	0.000487	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NTRK1—glaucoma	7.63e-06	0.000486	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SMO—glaucoma	7.55e-06	0.00048	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—C3—glaucoma	7.53e-06	0.000479	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—C3—glaucoma	7.36e-06	0.000468	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—TXN—glaucoma	7.21e-06	0.000459	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	7.15e-06	0.000455	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	7.09e-06	0.000451	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN2B—glaucoma	7.03e-06	0.000448	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SMO—glaucoma	7.01e-06	0.000446	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NTRK2—glaucoma	6.9e-06	0.000439	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—C3—glaucoma	6.84e-06	0.000435	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ABCA1—glaucoma	6.84e-06	0.000435	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP1B1—glaucoma	6.84e-06	0.000435	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	6.82e-06	0.000434	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EDN1—glaucoma	6.75e-06	0.00043	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NGFR—glaucoma	6.67e-06	0.000424	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NTRK2—glaucoma	6.41e-06	0.000408	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NTRK1—glaucoma	6.34e-06	0.000403	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NGF—glaucoma	6.2e-06	0.000395	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTT1—glaucoma	6.08e-06	0.000387	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—VEGFA—glaucoma	5.99e-06	0.000381	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTT1—glaucoma	5.93e-06	0.000378	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NGFR—glaucoma	5.92e-06	0.000377	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—C3—glaucoma	5.9e-06	0.000375	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN2B—glaucoma	5.84e-06	0.000372	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NTRK1—glaucoma	5.63e-06	0.000358	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EDN1—glaucoma	5.6e-06	0.000357	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTT1—glaucoma	5.59e-06	0.000356	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NGFR—glaucoma	5.5e-06	0.00035	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APOE—glaucoma	5.49e-06	0.000349	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTM1—glaucoma	5.47e-06	0.000348	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CAV1—glaucoma	5.44e-06	0.000346	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NTRK1—glaucoma	5.23e-06	0.000333	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	5.19e-06	0.00033	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FN1—glaucoma	5.18e-06	0.000329	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NGF—glaucoma	5.15e-06	0.000328	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—BAD—glaucoma	5.12e-06	0.000326	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EDN1—glaucoma	4.98e-06	0.000317	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	4.9e-06	0.000312	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—C3—glaucoma	4.89e-06	0.000311	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP1B1—glaucoma	4.84e-06	0.000308	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ABCA1—glaucoma	4.84e-06	0.000308	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—MTHFR—glaucoma	4.83e-06	0.000307	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	4.82e-06	0.000307	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP1B1—glaucoma	4.73e-06	0.000301	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ABCA1—glaucoma	4.73e-06	0.000301	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EDN1—glaucoma	4.62e-06	0.000294	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NGF—glaucoma	4.57e-06	0.000291	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APOE—glaucoma	4.56e-06	0.00029	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TP53—glaucoma	4.52e-06	0.000288	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CAV1—glaucoma	4.51e-06	0.000287	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—APOE—glaucoma	4.5e-06	0.000286	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CAV1—glaucoma	4.46e-06	0.000284	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP1B1—glaucoma	4.45e-06	0.000284	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ABCA1—glaucoma	4.45e-06	0.000284	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—C3—glaucoma	4.35e-06	0.000277	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FN1—glaucoma	4.3e-06	0.000273	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NGF—glaucoma	4.25e-06	0.00027	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—BAD—glaucoma	4.25e-06	0.00027	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NOS3—glaucoma	4.11e-06	0.000262	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APOE—glaucoma	4.05e-06	0.000258	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—C3—glaucoma	4.04e-06	0.000257	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CAV1—glaucoma	4.01e-06	0.000255	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTM1—glaucoma	3.87e-06	0.000246	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FN1—glaucoma	3.82e-06	0.000243	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTM1—glaucoma	3.78e-06	0.000241	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BAD—glaucoma	3.77e-06	0.00024	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APOE—glaucoma	3.76e-06	0.000239	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CAV1—glaucoma	3.73e-06	0.000237	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN1B—glaucoma	3.56e-06	0.000227	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTM1—glaucoma	3.56e-06	0.000227	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FN1—glaucoma	3.55e-06	0.000226	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BAD—glaucoma	3.5e-06	0.000223	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—MTHFR—glaucoma	3.42e-06	0.000218	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOS3—glaucoma	3.41e-06	0.000217	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—NOS3—glaucoma	3.37e-06	0.000214	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—MTHFR—glaucoma	3.34e-06	0.000213	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—glaucoma	3.3e-06	0.00021	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—APOE—glaucoma	3.19e-06	0.000203	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CAV1—glaucoma	3.16e-06	0.000201	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—MTHFR—glaucoma	3.15e-06	0.0002	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—APOE—glaucoma	3.11e-06	0.000198	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—glaucoma	3.08e-06	0.000196	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CAV1—glaucoma	3.08e-06	0.000196	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOS3—glaucoma	3.03e-06	0.000193	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—glaucoma	2.96e-06	0.000189	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN1B—glaucoma	2.96e-06	0.000188	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—APOE—glaucoma	2.93e-06	0.000187	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CAV1—glaucoma	2.9e-06	0.000185	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOS3—glaucoma	2.82e-06	0.000179	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—glaucoma	2.74e-06	0.000174	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	2.63e-06	0.000167	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—glaucoma	2.46e-06	0.000157	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	2.44e-06	0.000155	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—glaucoma	2.43e-06	0.000155	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NOS3—glaucoma	2.39e-06	0.000152	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NOS3—glaucoma	2.33e-06	0.000148	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—glaucoma	2.26e-06	0.000144	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—glaucoma	2.24e-06	0.000142	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NOS3—glaucoma	2.2e-06	0.00014	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—glaucoma	2.18e-06	0.000139	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—glaucoma	2.18e-06	0.000139	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—glaucoma	2.13e-06	0.000136	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—glaucoma	2.03e-06	0.000129	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—glaucoma	2.01e-06	0.000128	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—glaucoma	1.86e-06	0.000118	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—glaucoma	1.65e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—glaucoma	1.53e-06	9.76e-05	CbGpPWpGaD
